Search

everythinglearnresearchcommunity

for

Search:↓

EpiLife® media and younger donor age improve artificial skin model quality.

Different medications can cause serious side effects in some people.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

Hair thinning on top of the head is common in female androgenetic alopecia.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

FDG PET/CT can improve cancer treatment plans in dogs.

Testosterone affects skin by increasing oil production and influences hair growth.

Cinnamon essential oil can cause severe or unusual skin reactions, with cinnamaldehyde being the main allergen.

Hormones significantly affect hair growth and loss, with potential for new treatments.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

A Japanese patient with a rare genetic disorder had a less severe case than others, suggesting other factors may affect symptoms.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Hair follicles are complex, dynamic mini-organs that help us understand cell growth, death, migration, and differentiation, as well as tissue regeneration and tumor biology.

Histone demethylases can change gene expression and may be linked to diseases like cancer.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.